Heart Disease Trial, Recruiting (NCT05500859)

Heart Disease Trial, Recruiting NCT05500859 Sponsor: University Hospital, Basel, Switzerland Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05500859 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are taking part in an outpatient cardiac rehabilitation program (this is open to all age groups)
People who are able and willing to sign a written agreement to participate in the study

Who may not be able to join:

People who are unable to continue attending the outpatient cardiac rehabilitation program for more than 3 weeks
People who are not willing to sign the agreement to participate in the study
People who are unable to understand the participation agreement due to a language barrier
People who do not have the mental capacity to make their own decisions about joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Otmar Pfister, Prof. Dr. med., Outpatient Cardiology, University Hospital Basel

Phone: +41 61 328 7482

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05500859

Sponsor: University Hospital, Basel, Switzerland

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +41 61 328 7482

More information: https://clinicaltrials.gov/study/NCT05500859

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are taking part in an outpatient cardiac rehabilitation program (this is open to all age groups)
People who are able and willing to sign a written agreement to participate in the study

Who may not be able to join:

People who are unable to continue attending the outpatient cardiac rehabilitation program for more than 3 weeks
People who are not willing to sign the agreement to participate in the study
People who are unable to understand the participation agreement due to a language barrier
People who do not have the mental capacity to make their own decisions about joining the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Basel, Switzerland

Registry

ClinicalTrials.gov

Start date

20 December 2019

Est. completion

1 December 2035

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change in Guideline recommended medical therapy; Change in predefined secondary prevention benchmark performance measures (BPM) at one year after CR: LDL-Cholesterol target value; Change in predefined secondary prevention benchmark performance measures (BPM) at one year after CR: blood-pressure (systolic and diastolic); Change in smoking status; Change in predefined secondary prevention benchmark performance measures (BPM) at one year after CR: exercise/ week

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov